The pulse, right now.
A continuously-updating read on what the AI industry is doing, shipping, buying, and saying.
appeal 9.0Anthropic Explores Samsung AI Chip
AI developers are shifting control over hardware supply chains. Anthropic's talks with Samsung for a custom AI chip, following OpenAI's move, signal a broader industry drive to reduce reliance on single-vendor hardware, impacting long-term compute costs and deployment flexibility.
AI development races ahead, with firms pursuing custom silicon and specialised models. However, progress in agents slows, and ethical considerations, like AI music royalties and code contributions, demand careful naviga…
The stream
- RESEARCHAnthropic Anthropic Explores Samsung AI Chip9.0
- RESEARCHMeta AI Agent Meta AI Agent progress slows9.0
- INVESTMENTChina AI Drug Deals China AI Drug Deals Surge to $75 Billion9.0
- OPENSOURCEGitHub Copilot Adds Open-Weight Model Kimi K2.77.0
- POLICYOpenAI OpenAI Implements Hard API Spending Limits8.0
- FUNDINGSoftBank SoftBank guarantees OpenAI loan8.0
- RESEARCHSamsung Samsung advances quantum AI chipmaking research8.0
- RELEASEGemini Spark Google releases Gemini Spark for Mac7.0
- POLICYCloudflare Cloudflare blocks mixed AI crawlers by default7.0
- RESEARCHAnthropic, Sakana AI, Z.ai AI benchmarks show fragmented leadership8.0
- PRODUCTMeta Meta plans AI compute sales9.0
- INVESTMENTChipmakers Chipmakers add $2 trillion market cap9.0
- + more stories in the last 24 hoursAll stories →
Subjects
AI development races ahead, with firms pursuing custom silicon and specialised models.
A weekly synthesis of the most material AI-industry moves — what shipped, what was bought, what regulators said, and how the pattern is shifting.
Capital availability is no longer the primary constraint — return justification is.
Departments
All stories →
Meta AI Agent Progress Slows
Meta CEO Mark Zuckerberg revealed AI agent development has not met internal expectations, despite significant investment and restructuring. This signals persistent technical hurdles for agentic AI, requiring procurement teams to re-evaluate vendor roadmaps and security architects to reinforce human oversight.
China AI Drug Deals Surge
Chinese AI drug-design firms secured US$75 billion in out-licensing deals with global pharmaceutical companies in early 2026, a sharp rise from previous years. This provides a critical mechanism for pharma R&D teams to replenish pipelines, despite increasing US scrutiny and policy overhangs.
OpenAI Introduces Hard API Spending Limits
OpenAI now provides hard spending limits for its API, allowing users to cap monthly expenditure and prevent unexpected costs from autonomous agent activity. This mechanism helps procurement teams and platform engineers manage financial exposure and operational costs.
SoftBank Guarantees OpenAI Loan
SoftBank is offering a guarantee for a $10 billion loan backed by its OpenAI stake, shifting valuation risk back to the borrower. This illustrates a potential model for private asset-backed financing for large-scale AI investments, increasing scrutiny for founders and investors.
Samsung Advances Quantum AI Chipmaking
Samsung's development of quantum computing and AI for lithography simulations aims to cut chip manufacturing time and cost, while boosting density and yield. This initiative directly challenges established foundry leaders, impacting procurement strategies and investment in advanced silicon production.
Meta Plans AI Compute Sales
Meta's reported plan to launch "Meta Compute" to sell AI compute and models, leveraging its $182.9 billion infrastructure investment, introduces a new hyperscale provider. This diversifies supply for procurement teams and platform engineers, potentially impacting the cost curve for AI development.
Every Tuesday. 5-minute read. 34,925 unique readers.
A tight brief for CTOs, CFOs, product leads, and founders. No hype. No hedging. No filler.